Breaking News

Used to curb cancer drug side effects, leucovorin gets expanded use

September 23, 2025
Adobe

STAT+ | As medical AI use grows, industry payments to providers remain opaque

Few developers of FDA-authorized AI devices disclose payments to clinicians, raising concerns about conflicts of interest.

By Katie Palmer


STAT+ | Apple Watch's hypertension alert misses half of cases. Experts still think it will boost treatment

Experts say sensitivity rate may be low, just 41%, but that any feature that nudges people toward blood pressure care is a good thing.

By Mario Aguilar


STAT+ | Trump administration to close Miami organ donation group it calls 'failing'

The administration said the agency was being shut down due to underperformance, unsafe practices, paperwork errors.

By Associated Press



Natsumi Chikayasu for STAT

STAT+ | Hospitals get dinged for reporting too many infections. In some cases, the solution is not to test

To avoid fines for reporting excessive hospital-acquired infections, some facilities are dodging reports by discouraging testing. A STAT investigation by Tara Bannow.

By Tara Bannow


What the evidence tells us about Tylenol, leucovorin, and autism

Trump highlights old but unsettled claims: Tylenol-pregnancy autism risk, leucovorin's promise of improved autistic speech. Here's what the science says.

By Matthew Herper


More around STAT

In case you missed it


Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments